Top Stocks Above 50 DMA: Analysis of Info Edge, Sun Pharma, Cipla & Zydus – Jainam Broking Ltd
Start searching for stocks
Start searching for blogs
Start searching for circulars
Start searching for news
Start searching for articles

Top Stocks Above 50 DMA: Analysis of Info Edge, Sun Pharma, Cipla & Zydus

Written by Jainam Resources resources.jainam

Last Updated on: October 17, 2026

Summary

The 50 DMA is a popular indicator for measuring intermediate-term trends in stocks. If a stock is trading above this average, it indicates that momentum is improving, but the signal has to be confirmed by volume, resistance, support, valuation and fundamentals. Investors also need to compare the 50 DMA to the 200 DMA and have disciplined risk management.

Key Highlights

  • 50 DMA as a trend indicator: A price trading above a rising 50 DMA is generally an indication of stronger intermediate-term momentum.
  • Volume confirmation is important: A breakout that is accompanied by an increase in trading volume is generally considered to be more convincing than a breakout that occurs on low volume.
  • Combine technical and fundamental analysis: Look at the 50 DMA with earnings, valuation, support, resistance and sector conditions.
  • Risk management remains crucial: Even if a stock is above its 50 DMA, it doesn’t automatically become a buy. Traders should establish suitable stop-loss levels and be vigilant for possible false breakouts.

Understanding the 50-Day Moving Average (50 DMA) in Technical Analysis

The 50-day moving average, also known as the 50 DMA or 50-day SMA, is one of the most regularly used indicators in technical analysis. It is based on the closing price of a stock for the last 50 trading days. It is also used to check the medium-term price trend.

Typically, a stock trading above its 50 DMA means that the recent price action is higher than the medium-term average. On the flip side, a price below the 50 DMA means that sellers have been more in control of the recent trend. 

What Does Trading Above the 50 DMA Signal?

The indicator generally indicates that the intermediate-term momentum continues to be constructive if a stock is consistently trading above its 50 DMA. The moving average can act as a support level in an existing uptrend. Traders will often watch to see if the stock repeatedly sees buying interest near the average.

A move above the 50 DMA becomes more meaningful when it is accompanied by:

  • Higher trading volume.
  • Improving relative strength.
  • A rising 50 DMA.
  • Positive momentum indicators.
  • Higher highs and higher lows.
  • A breakout above an established resistance zone.

A simple intraday move above the moving average is considerably less significant than a sustained close above it. A false breakout can occur when a stock crosses the average temporarily but fails to maintain the level.

The opposite condition also deserves attention. If a stock is below its 50 DMA, it is not good for medium term momentum, especially if the 50 DMA is falling. If the stock also closes below its 200 DMA, then the broader technical structure will turn a little cautious.

Key Metrics to Look For: Volume, Resistance, and Support Levels

The 50 DMA should be assessed with other technical measures rather than considered in isolation.

MetricSignificancePreferred Signal
50 DMAIntermediate-term trendRising
200 DMALong-term trendPrice above average
Trading VolumeStrength of price movementIncreasing on breakouts
SupportPotential demand zonePrice repeatedly holds
ResistancePotential supply zoneBreakout with volume
RSIMomentumRising without excessive extension
MFIPrice-volume pressureImproving buying pressure
MACDTrend momentumPositive crossover

Volume is particularly important during a moving-average breakout. A stock crossing above the 50 DMA with substantially higher participation generally provides stronger confirmation than a low-volume move.

Support and resistance levels are equally relevant. If a stock trades above its 50 DMA but remains immediately below a major resistance zone, the potential risk-reward may be less attractive. Conversely, a decisive resistance breakout combined with a rising 50 DMA can strengthen the technical setup.

Detailed Analysis of the Stocks

Info Edge

Current Trend: Mixed.

Key Levels: Trading at ₹1,225.30, below its 50 DMA (₹1,288.30) but above its 200 DMA (₹1,146.20).

Outlook: RSI of 43.3 reflects subdued momentum. Reclaiming ₹1,288 on higher volume would improve the outlook, whereas a break below ₹1,146 would jeopardize the long-term structure.

Sun Pharma

Current Trend: Weak.

Key Levels: Trading at ₹1,781, below both its 50 DMA (₹1,896.20) and 200 DMA (₹1,807.50).

Outlook: RSI at 36.4 and negative MACD readings suggest persistent bearishness. Key support sits near ₹1,767 and ₹1,754, with resistance at ₹1,799 and ₹1,818. 

Cipla

Current Trend: Weak.

Key Levels: Trading at ₹1,327.20,below its 50 DMA (₹1,411) and 200 DMA (₹1,378.10).

Outlook: Weak RSI (32.0) and negative MACD point to sustained selling pressure. Support levels sit at ₹1,317.60, ₹1,308, and ₹1,291.30, while resistance lies between ₹1,343.90 and ₹1,370.20.

Zydus Lifesciences

Current Trend: Relatively Strong.

Key Levels: Trading near ₹1,115, below its 50 DMA (₹1,143.60) but comfortably above its 200 DMA (₹1,014.50).

Outlook: Positive MACD supports a constructive outlook, though RSI (47.6) and ADX (14.4) signal modest short-term trend strength.

Comparative Technical Analysis

Technical FactorInfo EdgeSun PharmaCiplaZydus Lifesciences
Price vs. 50 DMA1,288.3Day SMA50Price below SMA-501,896.2Day SMA50Price below SMA-501,411Day SMA50Price below SMA-501,143.6Day SMA50Price below SMA-50
Price vs. 200 DMA1,146.2Day SMA200Price above SMA-2001,807.5Day SMA200Price below SMA-2001,378.1Day SMA200Price below SMA-2001,014.5Day SMA200Price above SMA 1014.5
RSI43.336.432.047.6
Day MACD-13.8MACD is below its signal and centre line; this is a strong bearish indicator.-27.6 MACD is below its Signal and centre line; this is a strong bearish indicator.-18.1 MACD is below its Signal and centre line; this is a strong bearish indicator.11 MACD is above its centre line but below the signal line.
MFI49.439.550.864.4
Technical stanceMixedWeakWeakRelatively stronger
Key considerationReclaim 50 DMARecover 200 DMARecover 50/200 DMASustain above 50 DMA

The comparison indicates that Zydus currently has the strongest moving-average structure. Info Edge occupies an intermediate position because it remains above its 200 DMA despite trading below its 50 DMA. Sun Pharma and Cipla show greater technical weakness because their prices are below both the 50-day and 200-day averages.

Key Risks & What Traders Should Watch Out For

The biggest risk with the 50 DMA is using it on its own as a buy or sell signal. Moving averages are lagging indicators as they are based on past prices. They can confirm a trend but cannot reliably predict the beginning of one.

Traders should monitor:

  • False Breakouts: Rapid moves above the 50 DMA can reverse quickly. 
  • Volume confirmation: A breakout confirmed by higher volume is generally more significant from a technical standpoint.
  • 50 DMA direction: A rising average is generally more positive than a falling average 
  • 200 DMA position: The relation of the 50 DMA to the 200 DMA helps determine the wider trend.
  • Support failure: A decisive break of established support can negate a bullish setup.
  • Market-wide weakness: Individual stocks can remain under pressure even if the company-specific fundamentals are solid due to broad market weakness.
  • Risk management: Technical structure and position risk should determine stop loss levels.

Conclusions

The 50 DMA remains a useful tool for measuring medium-term momentum, but the latest data shows why technical analysis needs context. The latest data shows all four stocks trading below their respective 50 DMAs. Zydus Lifesciences had the narrowest gap and the strongest overall moving-average structure, while Sun Pharma and Cipla showed greater technical weakness below both major averages. Info Edge, Sun Pharma and Cipla were below their respective 50 DMAs.

Zydus therefore has the strongest current moving-average position, while Info Edge has a mixed technical structure as it remains above its 200 DMA. Sun Pharma and Cipla have weaker technical set-ups, with both trading below their 50-day and 200-day moving averages.

Therefore, a 50-DMA crossover should be considered part of a larger technical system. Investors should consider price action, volume, support, resistance, momentum, and the 200 DMA before making an investment decision. 

FAQs

Trading above the 50 DMA generally indicates that the stock’s current price is stronger than its average price over the preceding 50 trading sessions. It can indicate improving medium-term momentum, particularly when accompanied by rising volume and a rising moving average.

The four stocks provide different technical examples. Zydus Lifesciences is currently above its 50 DMA, while Info Edge, Sun Pharma, and Cipla are below theirs. Info Edge remains above its 200 DMA, whereas Sun Pharma and Cipla are below both major averages.

No. A move above the 50 DMA is only one technical signal. Traders should also assess volume, resistance, support, momentum indicators, the 200 DMA, broader market conditions, and the sustainability of the breakout.

The 50 DMA reflects medium-term price behavior, while the 200 DMA is used to assess the longer-term trend. A stock above both averages generally has a stronger technical structure than one trading below both.

Stop-loss levels should generally be tied to significant technical support, recent swing lows, or a clear risk level. The distance also needs to be a function of the stock volatility and the size of the trader’s position. A stop-loss should not be placed mechanically at a fixed percentage without considering the stock’s technical structure.

Disclaimer

This blog is for general informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. The information is based on publicly available sources and market understanding at the time of writing and may change due to global developments. Past performance of markets during geopolitical events does not guarantee future results. Readers are encouraged to conduct their own research and consult qualified professionals before making investment decisions. Jainam Broking does not provide any assurance regarding outcomes based on this information.

Explore our feature-rich web trading platform

Get the link to download the App

trading_platform
GET FREE DEMAT ACCOUNT
QR Code